Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor

Biochemical and Biophysical Research Communications
K KosaiT Nakamura

Abstract

Excessive activity of the Fas system in the liver is an essential event and contributor to fulminant hepatic failure, whose prognosis is extremely poor with high mortality due to lack of effective therapy. Administration of agonistic anti-Fas antibody to mice rapidly led to massive liver apoptosis and fulminant hepatic failure. In contrast, administration of human recombinant hepatocyte growth factor (HGF) abrogated Fas-induced massive liver apoptosis and the lethal hepatic failure. Addition of anti-Fas antibody to hepatocytes in primary culture induced cell death, but Fas-mediated cell death was potently suppressed by HGF. HGF strongly induced Bcl-xL expression and subsequently blocked Fas-mediated signaling pathway upstream of CPP32 in the liver. These results implicate a potential therapeutic usage of HGF for treatment of fulminant hepatic failure.

References

Nov 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y IshikiT Nakamura
Dec 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N ArakakiY Daikuhara
Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N HiramatsuT Kamada
Aug 26, 1993·Nature·J OgasawaraS Nagata
Jan 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G ShiotaT Nakamura
Jan 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H HoofnagleN Ascher
Feb 4, 1995·Lancet·P Boros, C M Miller
Apr 12, 1997·Lancet·A Mas, J Rodés

❮ Previous
Next ❯

Citations

Oct 6, 2007·Cell Death and Differentiation·D Tulasne, B Foveau
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·G MarinoD A Flockhart
Jan 26, 2002·Molecular and Cellular Biology·Markus MüllerCarola Ponzetto
Nov 16, 2004·Molecular and Cellular Biology·David TulasneVéronique Fafeur
Feb 5, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Young H LeeRegina M Day
Dec 20, 2000·The Journal of Clinical Investigation·T NakamuraT Nakamura
Feb 2, 1999·The Journal of Clinical Investigation·M TaharaT Nakamura
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Shingo NiimiTakao Hayakawa
Apr 2, 2005·Biological & Pharmaceutical Bulletin·Kaori HiramatsuEiichi Gohda
Jun 17, 2010·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Toshikazu Nakamura, Shinya Mizuno
May 1, 2007·Regenerative Medicine·Shinya Mizuno, Toshikazu Nakamura
Apr 23, 2013·International Journal of Hepatology·Neeta K Venepalli, Laura Goff
Jul 18, 2012·Proceedings of the American Thoracic Society·Bruno CrestaniMonique Dehoux
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chang-Goo HuhSnorri S Thorgeirsson
Dec 22, 1999·Journal of Viral Hepatitis·N Hayashi, E Mita
Jun 28, 2008·Amino Acids·Z SarangZ Szondy
Dec 17, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hiroshi Funakoshi, Toshikazu Nakamura
May 12, 2001·Critical Reviews in Clinical Laboratory Sciences·M G Neuman
Apr 23, 2004·Expert Opinion on Biological Therapy·Poornima RaoAdolfo Garcia-Ocaña
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Henning Schulze-BergkamenPeter H Krammer
Sep 18, 2002·Kidney International·Xiaojie GaoTakakuni Tanizawa
May 31, 2001·Kidney International·K Matsumoto, T Nakamura
Sep 29, 2011·Gastroenterology·Eric BourbonnaisMarc Bilodeau
Dec 25, 2015·Journal of Animal Science and Biotechnology·Hanfang CaiHong Chen
Dec 18, 2015·Clinical and Experimental Nephrology·Carmelo LibettaAntonio Dal Canton
Oct 31, 2008·Journal of Pediatric Surgery·Troy A MarkelDaniel R Meldrum
Oct 31, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anna E RutherfordUNKNOWN ALF Study Group
Sep 4, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Hideyuki SuzukiMasatomo Mori
Jul 25, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Akio Ido, Hirohito Tsubouchi
Jun 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Hussein M AttaOlfat A Hammam

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K KosaiT Nakamura
Liver International : Official Journal of the International Association for the Study of the Liver
Hideyuki SuzukiMasatomo Mori
The Journal of Immunology : Official Journal of the American Association of Immunologists
M WooT W Mak
© 2022 Meta ULC. All rights reserved